122 related articles for article (PubMed ID: 22341515)
1. Lipolysis and structure controlled drug release from reversed hexagonal mesophase.
Garti N; Hoshen G; Aserin A
Colloids Surf B Biointerfaces; 2012 Jun; 94():36-43. PubMed ID: 22341515
[TBL] [Abstract][Full Text] [Related]
2. Controlling insulin release from reverse hexagonal (H
Mishraki-Berkowitz T; Cohen G; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2018 Jan; 161():670-676. PubMed ID: 29172155
[TBL] [Abstract][Full Text] [Related]
3. Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac.
Bitan-Cherbakovsky L; Libster D; Appelhans D; Voit B; Aserin A; Garti N
J Phys Chem B; 2014 Apr; 118(14):4016-24. PubMed ID: 24617448
[TBL] [Abstract][Full Text] [Related]
4. Transitions induced by solubilized fat into reverse hexagonal mesophases.
Amar-Yuli I; Garti N
Colloids Surf B Biointerfaces; 2005 Jun; 43(2):72-82. PubMed ID: 15921902
[TBL] [Abstract][Full Text] [Related]
5. Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Control Release; 2012 May; 159(3):419-28. PubMed ID: 22306174
[TBL] [Abstract][Full Text] [Related]
6. Low viscosity reversed hexagonal mesophases induced by hydrophilic additives.
Amar-Yuli I; Wachtel E; Shalev DE; Aserin A; Garti N
J Phys Chem B; 2008 Apr; 112(13):3971-82. PubMed ID: 18324809
[TBL] [Abstract][Full Text] [Related]
7. Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A.
Libster D; Ishai PB; Aserin A; Shoham G; Garti N
Int J Pharm; 2009 Feb; 367(1-2):115-26. PubMed ID: 18977286
[TBL] [Abstract][Full Text] [Related]
8. On structural transitions in a discontinuous micellar cubic phase loaded with sodium diclofenac.
Efrat R; Aserin A; Garti N
J Colloid Interface Sci; 2008 May; 321(1):166-76. PubMed ID: 18279886
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
Milak S; Chemelli A; Glatter O; Zimmer A
Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
[TBL] [Abstract][Full Text] [Related]
11. Unit cell structure of water-filled monoolein in inverted hexagonal mesophase in the presence of incorporated tricaprylin and entrapped lysozyme.
Kolev V; Ivanova A; Madjarova G; Aserin A; Garti N
Eur Biophys J; 2016 Mar; 45(2):99-112. PubMed ID: 26424533
[TBL] [Abstract][Full Text] [Related]
12. Modulation of physical properties of reverse hexagonal mesophases: a dielectric spectroscopy study.
Mishraki T; Ben Ishai P; Babukh D; Aserin A; Feldman Y; Garti N
J Colloid Interface Sci; 2013 Apr; 396():178-86. PubMed ID: 23415506
[TBL] [Abstract][Full Text] [Related]
13. The dielectric study of insulin-loaded reverse hexagonal (H(II)) liquid crystals.
Mishraki-Berkowitz T; Ben Ishai P; Aserin A; Feldman Y; Garti N
Phys Chem Chem Phys; 2015 Apr; 17(14):9499-508. PubMed ID: 25767829
[TBL] [Abstract][Full Text] [Related]
14. Structural properties and release of insulin-loaded reverse hexagonal (HII) liquid crystalline mesophase.
Mishraki-Berkowitz T; Aserin A; Garti N
J Colloid Interface Sci; 2017 Jan; 486():184-193. PubMed ID: 27701016
[TBL] [Abstract][Full Text] [Related]
15. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
Libster D; Aserin A; Garti N
J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
[TBL] [Abstract][Full Text] [Related]
16. Lysozyme entrapped within reverse hexagonal mesophases: physical properties and structural behavior.
Mishraki T; Libster D; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):47-56. PubMed ID: 19748240
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of gabapentin into HII mesophases.
Achrai B; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Feb; 115(5):825-35. PubMed ID: 21182317
[TBL] [Abstract][Full Text] [Related]
18. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac.
Cohen-Avrahami M; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):131-8. PubMed ID: 20189781
[TBL] [Abstract][Full Text] [Related]
19. Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery.
Cohen-Avrahami M; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Sep; 115(34):10189-97. PubMed ID: 21749044
[TBL] [Abstract][Full Text] [Related]
20. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
